• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,139
109
75
71
68

COUNTRY

70
22
16
10
9

CATEGORIES

  • 574
  • 118
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

879
1,165
1,601
2,946

PUBLISHED

152
222
686
2,946

PRODUCT TYPE

2,375
494
67
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014 HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient...

July 2014
FROM
Lymphoma Drug Pathway Analyzer 2014 Lymphoma Drug Pathway Analyzer 2014 - Product Thumbnail Image

Lymphoma Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 350 targeted molecular therapies known to affect more than 235 specific intracellular signaling pathways...

July 2014
FROM
Bladder Cancer Drug Pathway Analyzer 2014 Bladder Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Bladder Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 99 targeted molecular therapies known to affect more than 215 specific intracellular signaling pathways...

July 2014
FROM
Melanoma Drug Pathway Analyzer 2014 Melanoma Drug Pathway Analyzer 2014 - Product Thumbnail Image

Melanoma Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 282 targeted molecular therapies known to affect more than 251 specific intracellular signaling pathways...

July 2014
FROM
Protein Kinase Inhibitors Drug Pathway Analyzer 2014 Protein Kinase Inhibitors Drug Pathway Analyzer 2014 - Product Thumbnail Image

Protein Kinase Inhibitors Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 963 protein kinase inhibitor drugs known to affect more than 250 specific intracellular signaling pathways...

July 2014
FROM
Targeting Tight Junctions in Cancer Drug Pipeline Update 2014 Targeting Tight Junctions in Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

Targeting Tight Junctions in Cancer Drug Pipeline Update 2014

Epithelial tight junctions (TJs) are composed of at least three types of transmembrane protein -occludin, claudin and junctional adhesion molecules (JAMs)- and a cytoplasmic 'plaque' consisting of many...

July 2014
FROM
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014 Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

There are today 149 companies plus partners developing 156 metabolic pathways targeting drugs in 436 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number...

July 2014
FROM
Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014 Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014

There are today 183 companies plus partners developing 319 targeting actin cytoskeleton modulators drugs in 1200 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated...

July 2014
FROM
Brain Cancer Drug Pathway Analyzer 2014 Brain Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Brain Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 213 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways...

July 2014
FROM
Immunotherapy in Oncology: Drug Pathway Analyzer 2014 Immunotherapy in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 811 immunotherapy drugs known to affect more than 234 specific intracellular signaling pathways for...

July 2014
FROM
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014 NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014

Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more...

July 2014
FROM
Viral Carcinogenesis Drug Pipeline Update 2014 Viral Carcinogenesis Drug Pipeline Update 2014 - Product Thumbnail Image

Viral Carcinogenesis Drug Pipeline Update 2014

There is a strong association between viruses and the development of human malignancies. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus...

July 2014
FROM
Hematological Cancers Drug Pathway Analyzer 2014 Hematological Cancers Drug Pathway Analyzer 2014 - Product Thumbnail Image

Hematological Cancers Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 672 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways...

July 2014
FROM
Colorectal Cancer Drug Pathway Analyzer 2014 Colorectal Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Colorectal Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 375 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways...

July 2014
FROM
Gastrointestinal Cancer Drug Pathway Analyzer 2014 Gastrointestinal Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Gastrointestinal Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 185 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways...

July 2014
FROM
Ovarian Cancer Drug Pathway Analyzer 2014 Ovarian Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Ovarian Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 320 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways...

July 2014
FROM
Prostate Cancer Drug Pathway Analyzer 2014 Prostate Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Prostate Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways...

July 2014
FROM
Peptides in Oncology: Drug Pathway Analyzer 2014 Peptides in Oncology: Drug Pathway Analyzer 2014 - Product Thumbnail Image

Peptides in Oncology: Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 188 peptide drugs known to affect more than 216 specific intracellular signaling pathways for the treatment...

July 2014
FROM
MicroRNAs in Cancer Drug Pipeline Update 2014 MicroRNAs in Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

MicroRNAs in Cancer Drug Pipeline Update 2014

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities either...

July 2014
FROM
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014 IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014 - Product Thumbnail Image

IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014

The IL-2 signaling pathway activates the Ras/MAPK, JAK/Stat and PI 3-kinase/Akt signaling modules. There are today 244 companies plus partners developing 370 IL-2 pathway targeting drugs in 1307 developmental...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos